In this regard, experiments of quantitative proteomics carried out on the AD triple transgenic mouse model (pR5/APPsw/PS2 N141I) revealed that the deregulation of the activity of complex I was tau dependent, while that of complex IV was Aβ dependent. Here, MAPT is linked to Alzheimer disease.